CSafe launches transport packaging for gene therapy market

Pharma packaging firm CSafe Global has launched a new product for the cell and gene therapy market.

CSafe said the passive AcuTemp Plus Series of packaging solutions has been designed with “proprietary, high-performance ThermoCor Vacuum Insulated Panels (VIP) to guarantee precise end-to-end control of internal payload temperatures”. 

“We are proud to expand our cold chain packaging offerings for the cell and gene therapy market, and have focused and invested significantly in R&D to develop best-in-class solutions to meet the demanding product requirements for this emerging class of medication,” stated Patrick Schafer, chief executive of CSafe Global.

“Test results of the new AcuTemp Plus Series have been very impressive with temperature performances outlasting other market available solutions by a large margin.”

Share this story

Related Topics

Latest pharma logistics news

LATAM and Delta expand partnership on pharma transport

LATAM Cargo and Delta Cargo are ramping up their partnership on pharma transport with the addition of new stations to…

Read More

Share this story

WestJet Cargo to launch time-sensitive Priority service

WestJet Cargo plans to launch a Priority product for time-sensitive shipments that gives top priority for loading and transport, guaranteeing…

Read More

Share this story

Virgin resurrects cargo-only Brussels flights

Virgin Atlantic will resurrect its cargo-focused flights between Heathrow and Brussels, this time utilising passenger aircraft to carry cargo. Today,…

Read More

Share this story

Damian Brett

Damian Brett
I have been writing about the freight and logistics industry since 2007 when I joined International Freighting Weekly to cover the shipping sector. After a stint in PR, I have gone on to work for Containerisation International and Lloyds List - where I was editor of container shipping - before joining Air Cargo News in 2015. Contact me on [email protected]